Cargando…

Loss of SUSD2 expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma

There is limited evidence regarding the relationship between the expression of Sushi Domain Containing 2 (SUSD2) and prognosis of patients with surgically resected lung adenocarcinoma (LUAD). This retrospective study aimed to investigate the clinical significance of SUSD2 expression in LUAD. To asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Wei, Shao, Fei, Sun, Sijin, Song, Peng, Guo, Lei, Xue, Xuemin, Zhang, Guochao, Zhang, Hao, Gao, Yibo, Qiu, Bin, Tan, Fengwei, Gao, Shugeng, He, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052850/ https://www.ncbi.nlm.nih.gov/pubmed/32194777 http://dx.doi.org/10.7150/jca.39319

Ejemplares similares

Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma
por: Gao, Yibo, et al.
Publicado: (2019)

Specific organ metastases and prognosis in lung adenocarcinoma
por: Zhao, Ziran, et al.
Publicado: (2023)

Preoperative systemic immune-inflammation index and prognostic nutritional index predict prognosis of patients with pulmonary neuroendocrine tumors after surgical resection
por: He, Huayu, et al.
Publicado: (2020)

Systemic immune‐inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non‐small cell lung cancer
por: Guo, Wei, et al.
Publicado: (2019)

Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for stage I lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2022)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022)

Prognostic value of tumor-infiltrating lymphocytes in esophageal cancer: an updated meta-analysis of 30 studies with 5,122 patients
por: Gao, Yibo, et al.
Publicado: (2020)

Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2020)

Development and validation of a nomogram for predicting survival in patients with surgically resected lung invasive mucinous adenocarcinoma
por: Zhang, Guochao, et al.
Publicado: (2021)

In Vitro Implantation Model Using Human Endometrial SUSD2(+)
por: Rahimipour, Marzieh, et al.
Publicado: (2021)

Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma
por: Gao, Shugeng, et al.
Publicado: (2021)

Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
por: Sun, Sijin, et al.
Publicado: (2021)

The surgical management of early-stage lung adenocarcinoma: is wedge resection effective?
por: Ji, Ying, et al.
Publicado: (2021)

Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma
por: Guo, Wei, et al.
Publicado: (2021)

The Complement Regulator Susd4 Influences Nervous-System Function and Neuronal Morphology in Mice
por: Zhu, Hongling, et al.
Publicado: (2020)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
por: Qiu, Bin, et al.
Publicado: (2021)

Loss of LIMCH1 predicts poor prognosis in patients with surgically resected Lung Adenocarcinoma: A study based on Immunohistochemical Analysis and Bioinformatics
por: Cao, He, et al.
Publicado: (2021)

Effect and Prognosis Factors of Combining Laparoscopic Radical Resection of Colon Adenocarcinoma with Docetaxel Therapy in Treating Middle and Advanced Colon Adenocarcinoma
por: Gao, Qi, et al.
Publicado: (2022)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells
por: Zhang, Shaqiu, et al.
Publicado: (2017)

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer
por: Zhao, Ziran, et al.
Publicado: (2023)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

Structure of BT_3984, a member of the SusD/RagB family of nutrient-binding molecules
por: Bakolitsa, Constantina, et al.
Publicado: (2010)

SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer
por: Hultgren, Elizabeth M., et al.
Publicado: (2017)

RON, ROR1 and SUSD2 expression in tissues of endometrial carcinoma patients. Clinicopathological and prognostic implications
por: Abdelbary, Abeer M., et al.
Publicado: (2022)

Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes
por: Li, Renda, et al.
Publicado: (2021)

The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer
por: Wang, Juhong, et al.
Publicado: (2022)

Sintilimab for the treatment of non-small cell lung cancer
por: Zhang, Lin, et al.
Publicado: (2022)

High SNRPA1 expression leads to poor prognosis in patients with lung adenocarcinoma
por: Yang, Juan Juan, et al.
Publicado: (2023)

Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis
por: Shao, Fei, et al.
Publicado: (2019)

Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer
por: Guo, Wei, et al.
Publicado: (2022)

Single‐cell RNA sequencing analysis reveals transcriptional heterogeneity of multiple primary lung cancer
por: Guo, Wei, et al.
Publicado: (2023)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients
por: Englund, Emelie, et al.
Publicado: (2015)

Comparison of surgical difficulty in patients with resectable non-small cell lung cancer under different neoadjuvant treatment modes: a retrospective cohort study
por: Zhang, Fan, et al.
Publicado: (2021)

Comprehensive analyses of N (6)‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer
por: Luo, Yuejun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_habq9penfnlecedog7nc8ktrkq